| Glenville Center | |
| 111 Fairground Road, Glenville, West Virginia 26351 | |
| (304) 462-5718 | |
| Name | Glenville Center |
|---|---|
| Location | 111 Fairground Road, Glenville, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 65 |
| Occupancy Rate | 75.23% |
| Medicare ID (CCN) | 515103 |
| Legal Business Name | Sunbridge Glenville Health Care Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1073290698 |
| Organization Name | GLENVILLE SNF OPERATIONS LLC |
| Address | 111 Fairground Rd, Glenville, WV 26351 |
| Phone Number | 304-462-5718 |
News Archive
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
An international team of scientists, led by Todd Lencz, PhD, professor at The Feinstein Institute for Medical Research at Northwell Health and Hofstra Northwell School of Medicine, have unlocked some of the genes responsible for cognitive ability.
The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.
The Center for Science in the Public Interest was joined today by victims, consumer advocacy, and public health organizations in urging Congress to support the Food and Drug Administration (FDA) efforts to protect consumers from contaminated oysters that each year cause scores of serious illnesses and deaths. The blood infection caused by Vibrio vulnificus bacteria in oysters is one of the most deadly foodborne illnesses, killing half of the people infected. Those who survive can have painful lesions and fluid-filled blisters all over their bodies, sometimes requiring limbs to be amputated. Four methods of post-harvest processing have proven effective at destroying the bacteria without harming the texture or flavor of the oysters.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
An international team of scientists, led by Todd Lencz, PhD, professor at The Feinstein Institute for Medical Research at Northwell Health and Hofstra Northwell School of Medicine, have unlocked some of the genes responsible for cognitive ability.
The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.
The Center for Science in the Public Interest was joined today by victims, consumer advocacy, and public health organizations in urging Congress to support the Food and Drug Administration (FDA) efforts to protect consumers from contaminated oysters that each year cause scores of serious illnesses and deaths. The blood infection caused by Vibrio vulnificus bacteria in oysters is one of the most deadly foodborne illnesses, killing half of the people infected. Those who survive can have painful lesions and fluid-filled blisters all over their bodies, sometimes requiring limbs to be amputated. Four methods of post-harvest processing have proven effective at destroying the bacteria without harming the texture or flavor of the oysters.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $47596 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.71 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.9 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.66 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.76 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.37 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.02 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.69 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 23.32 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 59.05 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.3 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.35 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.85 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.25 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 70.89 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.65 | 82.93 |
News Archive
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
An international team of scientists, led by Todd Lencz, PhD, professor at The Feinstein Institute for Medical Research at Northwell Health and Hofstra Northwell School of Medicine, have unlocked some of the genes responsible for cognitive ability.
The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.
The Center for Science in the Public Interest was joined today by victims, consumer advocacy, and public health organizations in urging Congress to support the Food and Drug Administration (FDA) efforts to protect consumers from contaminated oysters that each year cause scores of serious illnesses and deaths. The blood infection caused by Vibrio vulnificus bacteria in oysters is one of the most deadly foodborne illnesses, killing half of the people infected. Those who survive can have painful lesions and fluid-filled blisters all over their bodies, sometimes requiring limbs to be amputated. Four methods of post-harvest processing have proven effective at destroying the bacteria without harming the texture or flavor of the oysters.
› Verified 3 days ago